Stockreport

iTeos Therapeutics: ESMO Data Showing Signs Of A Real Win For TIGIT [Seeking Alpha]

iTeos Therapeutics, Inc.  (ITOS) 
PDF Follow Play 9min Summary iTeos Therapeutics' belrestotug shows promising response rates in lung cancer trials, especially when combined with dostarlimab, despit [Read more]